Table 2.
Patient number | FAB classification | Sex | Age | HLA-G expression | Karyotype |
---|---|---|---|---|---|
1 | AML-M2 | F | 83 | Positive | 46XX +8[4];[16] |
3 | sAML | F | 69 | Negative | 46XX |
5 | AML-M4 | F | 54 | Positive | 46XX |
9 | AML-M4 | F | 44 | Negative | 46XX |
10 | AML-M2 | M | 60 | Positive | 46XY t(8; 21)(q22;q22), del(9)(q?22) |
11 | AML-M4 | M | 70 | Positive | 46XY[19]; +21[2]; iso p21[1] |
18 | AML-M2 | F | 68 | Negative | 46XX iso 8p |
19 | AML-M4 | F | 76 | Positive | 46XX |
20 | AML-M0 | F | 83 | Positive | 46XX −7/t(1;7;4;12)[12] |
21 | AML-M2 | F | 66 | Positive | 46XX +8[4];[16] |
23 | AML-M2 | M | 74 | Positive | 46XY |
34 | AML-M0 | F | 72 | Negative | 46XX |
36 | AML-M6 | M | 53 | Positive | 46XY complex(del5q,-10 14; 19, 7p-)[20] |
37 | AML-M2 | F | 59 | Negative | 46XX |
38 | AML | M | 59 | Positive | 46XY |
39 | AML-M1 | F | 47 | Negative | 46XX |
41 | AML-M4 | F | 41 | Negative | 46XY |
44 | AML | M | 36 | Positive | 46XY |
45 | AML-M4 | F | 44 | Positive | 46XX |
49 | AML-M2 | M | 77 | Positive | 46XY |
54 | AML-M3 | M | 22 | Positive | 46XY[6], t(15;17)[5] |
55 | AML-M5a | F | 58 | Positive | 46XX |